Skip to main content

Security report for takarabio.com

Takara Bio USA, Inc. · Healthcare · United States

Low risk. 4 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

78/100

Risk levelLow

0–100, higher is better. How it is calculated

Takara Bio USA, Inc. is a prominent biotechnology company specializing in providing kits, reagents, instruments, and services to researchers focused on gene discovery, regulation, and function. As part of the Takara Bio Group, the company holds a strong market position with a commitment to advancing biotechnology and improving human health. Their offerings include custom enzyme services, OEM manufacturing, and gene and cell therapy manufacturing, targeting the scientific research community globally. The website infrastructure leverages modern web technologies including JavaScript frameworks, third-party marketing and analytics tools such as Marketo, Qualtrics, and Google Tag Manager, and video content delivery via Brightcove. The site is well-optimized for mobile and accessibility, with a professional design and clear navigation, supporting a positive user experience. Security posture is solid with HTTPS enforced and cookie consent mechanisms in place, though there is room for improvement in implementing additional security headers and enhancing incident response visibility. Privacy compliance is well addressed with comprehensive privacy and cookie policies aligned with GDPR requirements. Overall, the website presents a trustworthy and professional digital presence for Takara Bio USA, Inc., though the absence of publicly available WHOIS data slightly reduces domain trustworthiness. Strategic recommendations include enhancing security headers, auditing third-party scripts, and improving incident response contact information to further strengthen security and compliance.

Scanned

NIS2 and GDPR posture

GDPR outside view
68/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching takarabio.com

This scan found 18 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
77
Security headers
50
Email security
85
DNS health
85
Network security
100
GDPR outside view
68
Average
78

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Takara Bio USA, Inc. operates in the healthcare and biotechnology sector, serving research institutions and biotech companies. Their business model is B2B, focusing on supplying high-quality research products and custom services. The company benefits from a strong brand portfolio including Clontech and Cellartis, and holds ISO 13485:2016 certification indicating quality manufacturing standards. The website content and structure indicate a mature organization with a global footprint, supported by multiple marketing and analytics platforms. Growth indicators include new product launches, special offers, and educational content. The company maintains active social media channels and provides comprehensive customer support, reinforcing its market presence and customer engagement.

Security posture

The website demonstrates a moderate to good security maturity level with HTTPS enforced and a cookie consent mechanism compliant with privacy regulations. However, the lack of several important security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options suggests potential areas for improvement. No vulnerabilities or exposed sensitive data were detected in the HTML content. The use of multiple third-party marketing and analytics scripts necessitates regular security audits to mitigate risks. Incident response and security policy information are not prominently available, indicating a gap in transparency and readiness. Overall, the security posture is adequate for a corporate research website but could be enhanced to meet higher standards.

Recommendations

  1. Implement comprehensive security headers including Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options to mitigate common web attacks.
  2. Conduct regular security audits of third-party scripts and marketing tools to prevent supply chain vulnerabilities.
  3. Publish clear incident response and security policy information to improve transparency and preparedness.
  4. Enhance domain WHOIS information availability to improve trust and legitimacy perception.
  5. Maintain and update privacy and cookie policies to ensure ongoing compliance with evolving regulations.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Takara Bio USA, Inc.
Description
Takara Bio provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. The company is committed to improving the human condition through biotechnology and offers products under Takara, Clontech, and Cellartis brands.
Key services
Custom enzyme service partnerships, OEM manufacturing, Gene and cell therapy manufacturing services, Technical support and customer service
Content quality
excellent
Branding
consistent

Technology

Stack
JavaScript, jQuery, Brightcove video player, Google Tag Manager, Marketo Munchkin, Qualtrics, Osano Consent Management
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
75/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism implemented
  • No exposed sensitive data found in HTML

Analytics and tracking

Services
Marketo Munchkin, Google Tag Manager, Qualtrics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Marketo Munchkin, Qualtrics
Marketing tools
Marketo, Qualtrics, Google Optimize
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is professionally designed and content-rich.
  2. Strong focus on biotechnology research products and services.
  3. Comprehensive cookie and privacy policies with consent mechanisms.
  4. No signs of adult or inappropriate content.
  5. WHOIS data unavailable, which is uncommon for a corporate domain.
  6. Use of multiple third-party marketing and analytics tools.
  7. No detected WAF or blocking mechanisms.
Technical notes

Notes

The website uses a modern technology stack with JavaScript, jQuery, and integrates third-party services such as Marketo for marketing automation, Qualtrics for feedback, and Brightcove for video content. The site includes responsive design and accessibility features, contributing to a good user experience across devices. Performance is moderate, with potential optimization opportunities in script loading and resource management. No CMS was explicitly detected, suggesting a custom or proprietary platform. Hosting provider details are not disclosed. Overall, the technical infrastructure supports the business needs effectively but could benefit from performance tuning and enhanced security configurations.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with takarabio.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review takarabio.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.